X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17180) 17180
Book Review (1776) 1776
Publication (725) 725
Newsletter (160) 160
Magazine Article (92) 92
Book Chapter (56) 56
Conference Proceeding (21) 21
Dissertation (19) 19
Trade Publication Article (12) 12
Book / eBook (9) 9
Newspaper Article (9) 9
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13707) 13707
humans (11499) 11499
male (5929) 5929
female (5530) 5530
adult (4089) 4089
trimethoprim (3840) 3840
trimethoprim, sulfamethoxazole drug combination - therapeutic use (3389) 3389
middle aged (3101) 3101
trimethoprim - therapeutic use (3016) 3016
trimethoprim-sulfamethoxazole (2749) 2749
infectious diseases (2365) 2365
sulfamethoxazole - therapeutic use (2243) 2243
microbiology (2163) 2163
animals (2095) 2095
aged (2089) 2089
abridged index medicus (2041) 2041
antibiotics (1911) 1911
anti-bacterial agents - therapeutic use (1837) 1837
trimethoprim - pharmacology (1804) 1804
microbial sensitivity tests (1749) 1749
child (1736) 1736
pharmacology & pharmacy (1723) 1723
adolescent (1691) 1691
sulfamethoxazole (1616) 1616
anti-bacterial agents - pharmacology (1556) 1556
anti-infective agents - therapeutic use (1549) 1549
drug combinations (1541) 1541
trimethoprim, sulfamethoxazole drug combination (1399) 1399
child, preschool (1338) 1338
medicine, general & internal (1213) 1213
drug therapy, combination (1175) 1175
infant (1171) 1171
infections (1153) 1153
trimethoprim - administration & dosage (1112) 1112
immunology (1103) 1103
urinary tract infections - drug therapy (1102) 1102
drug resistance, microbial (1046) 1046
trimethoprim, sulfamethoxazole drug combination - adverse effects (1015) 1015
aids/hiv (1000) 1000
treatment outcome (971) 971
trimethoprim - adverse effects (946) 946
trimethoprim, sulfamethoxazole drug combination - administration & dosage (907) 907
drug combinations - therapeutic use (903) 903
drug resistance (869) 869
risk factors (854) 854
trimethoprim, sulfamethoxazole drug combination - pharmacology (836) 836
pneumonia, pneumocystis - drug therapy (834) 834
bacteria (793) 793
sulfamethoxazole - pharmacology (783) 783
escherichia coli - drug effects (747) 747
sulfamethoxazole - administration & dosage (745) 745
retrospective studies (728) 728
health aspects (726) 726
research (725) 725
sulfamethoxazole - adverse effects (696) 696
time factors (694) 694
therapy (689) 689
infection (685) 685
children (662) 662
pediatrics (661) 661
antibacterial agents (652) 652
antimicrobial resistance (639) 639
ciprofloxacin (639) 639
drug therapy (637) 637
escherichia-coli (630) 630
pneumonia (621) 621
aids (620) 620
analysis (620) 620
prophylaxis (619) 619
prevalence (564) 564
recurrence (564) 564
resistance (561) 561
antimicrobial agents (559) 559
administration, oral (550) 550
hiv (545) 545
pneumonia, pneumocystis - prevention & control (541) 541
clinical trials as topic (540) 540
sulfonamides (534) 534
drug resistance in microorganisms (532) 532
epidemiology (532) 532
escherichia coli (529) 529
anti-infective agents - adverse effects (527) 527
acute disease (525) 525
bacterial infections - drug therapy (520) 520
diagnosis (508) 508
drug resistance, bacterial (505) 505
prospective studies (498) 498
care and treatment (495) 495
urinary tract infections - microbiology (491) 491
aged, 80 and over (481) 481
anti-bacterial agents - administration & dosage (455) 455
anti-infective agents, urinary - therapeutic use (453) 453
antibiotic resistance (446) 446
genes (443) 443
trimethoprim - metabolism (435) 435
urinary tract infections (435) 435
susceptibility (430) 430
prevention (426) 426
co-trimoxazole (424) 424
mortality (421) 421
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15167) 15167
German (609) 609
French (565) 565
Spanish (325) 325
Japanese (129) 129
Italian (126) 126
Polish (80) 80
Chinese (77) 77
Turkish (68) 68
Russian (63) 63
Dutch (55) 55
Portuguese (42) 42
Danish (38) 38
Czech (32) 32
Swedish (29) 29
Norwegian (28) 28
Korean (23) 23
Hungarian (20) 20
Hebrew (14) 14
Finnish (10) 10
Romanian (10) 10
Slovak (9) 9
Bulgarian (7) 7
Croatian (6) 6
Serbian (3) 3
Arabic (2) 2
Icelandic (2) 2
Lithuanian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bioconjugate Chemistry, ISSN 1043-1802, 11/2018, Volume 29, Issue 11, pp. 3935 - 3935
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 11/2017, Volume 45, Issue 11, pp. 1146 - 1147
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 26, pp. 2545 - 2555
There are limited data on the role of antimicrobials in the treatment of skin abscesses. In this trial, clindamycin or trimethoprim–sulfamethoxazole was found... 
CLINICAL-PRACTICE GUIDELINES | SOFT-TISSUE INFECTIONS | MEDICINE, GENERAL & INTERNAL | AMERICA | MANAGEMENT | STAPHYLOCOCCUS-AUREUS INFECTIONS | ADULTS | RISK | DISEASES SOCIETY | TRIMETHOPRIM-SULFAMETHOXAZOLE | CHILDREN | Prospective Studies | Humans | Child, Preschool | Infant | Male | Skin Diseases, Bacterial - drug therapy | Anti-Bacterial Agents - therapeutic use | Clindamycin - adverse effects | Staphylococcal Skin Infections - drug therapy | Abscess - therapy | Adult | Female | Abscess - drug therapy | Anti-Bacterial Agents - adverse effects | Child | Double-Blind Method | Staphylococcus aureus - isolation & purification | Combined Modality Therapy | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Clindamycin - therapeutic use | Drainage | Skin Diseases, Bacterial - therapy | Adolescent | Intention to Treat Analysis | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Care and treatment | Usage | Clindamycin | Patient outcomes | Surgery | Abscess | Staphylococcus aureus infections | Causes of | Dosage and administration | Drug therapy | Complications | Hypersensitivity | Clinical trials | Trimethoprim | Staphylococcus infections | Antimicrobial agents | Cellulitis | Drug resistance | Clinical outcomes | Methicillin | Studies | Trimethoprim-sulfamethoxazole | Sulfamethoxazole | Side effects | Motivation | Antibiotics | Abscesses | Skin | Children | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
PLoS Biology, ISSN 1544-9173, 06/2017, Volume 15, Issue 6, pp. e2001644 - e2001644
Antibiotic-resistant infections kill approximately 23,000 people and cost $20,000,000,000 each year in the United States alone despite the widespread use of... 
GRAM-NEGATIVE BACTERIA | ANTIMICROBIAL DRUG | ANTIBACTERIAL ACTIVITY | COMBINATION THERAPY | PLASMODIUM-FALCIPARUM | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCHERICHIA-COLI K-12 | BIOLOGY | NUCLEOSIDE DIPHOSPHATE KINASE | VIVO ZEBRAFISH ASSAYS | SOS RESPONSE | FLUCTUATION ANALYSIS | Trimethoprim - chemistry | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Embryo, Nonmammalian - drug effects | Reverse Transcriptase Inhibitors - chemistry | Anti-Infective Agents, Urinary - therapeutic use | Biological Assay | Trimethoprim - agonists | Anti-Infective Agents, Urinary - chemistry | Anti-Infective Agents, Urinary - pharmacology | Escherichia coli Infections - drug therapy | Bacterial Proteins - antagonists & inhibitors | Computational Biology | Trimethoprim - therapeutic use | Mutation Rate | Escherichia coli Infections - metabolism | Drug Synergism | Small Molecule Libraries | Klebsiella pneumoniae - growth & development | Anti-Bacterial Agents - pharmacology | Mutation | Folic Acid Antagonists - pharmacology | Folic Acid Antagonists - chemistry | Trimethoprim - pharmacology | Sulfamethizole - agonists | Embryo, Nonmammalian - metabolism | Klebsiella Infections - metabolism | Reverse Transcriptase Inhibitors - pharmacology | Zebrafish - embryology | Folic Acid Antagonists - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Sulfamethizole - chemistry | Anti-Bacterial Agents - chemistry | Drug Resistance, Multiple, Bacterial | Sulfamethizole - pharmacology | Drug Design | Escherichia coli - metabolism | Sulfamethizole - therapeutic use | Escherichia coli - growth & development | Klebsiella pneumoniae - metabolism | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Klebsiella Infections - drug therapy | Bacterial Proteins - genetics | Escherichia coli Infections - microbiology | Embryo, Nonmammalian - microbiology | Klebsiella Infections - microbiology | Animals | High-Throughput Screening Assays | Bacterial Proteins - metabolism | Pattern Recognition, Automated | Klebsiella | Escherichia coli | Virulence | Homeostasis | Trimethoprim | Hydroxyurea | Identification | Biosynthesis | Infections | Urinary tract | Drug resistance | Drug development | Synergism | Folic acid | Design | Immunology | Historical account | E coli | New combinations | Antibiotic resistance | Bacteria | Libraries | Deoxyribonucleic acid--DNA | Effectiveness | Bacterial infections | Mutants | Medicine | DNA biosynthesis | Pathology | Sulfamethizole | Antibiotics | Collection | AZT | Zidovudine | Bypasses | Methods | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 2016, Volume 38, Issue 3, pp. 319 - 326
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 04/2019, Volume 47, Issue 4, pp. 392 - 392
Journal Article
mBio, ISSN 2161-2129, 09/2017, Volume 8, Issue 5, p. e01357-17
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 1, pp. 41 - 53
Co-trimoxazole is effective in preventing opportunistic infections in persons with advanced HIV infection. In this trial in southern Africa, prolonged... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | COTE-DIVOIRE | INSECTICIDE-TREATED BEDNETS | UGANDAN CHILDREN | OPPORTUNISTIC INFECTIONS | MALARIA | ANTIRETROVIRAL THERAPY | TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS | HUMAN-IMMUNODEFICIENCY-VIRUS | HIV-1-INFECTED ADULTS | Anti-Retroviral Agents - therapeutic use | Anti-Infective Agents - adverse effects | Follow-Up Studies | Humans | Kaplan-Meier Estimate | Anti-Infective Agents - therapeutic use | Child, Preschool | Hospitalization - statistics & numerical data | Male | CD4 Lymphocyte Count | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Withholding Treatment | Malaria - prevention & control | Adolescent | HIV Infections - complications | Female | HIV Infections - drug therapy | HIV Infections - mortality | Malaria - complications | Uganda | Zimbabwe | Child | Antiviral agents | Evaluation | Usage | Care and treatment | Control | Co-trimoxazole | Influence | HIV infection | Morbidity | Adolescence | Pneumonia | Malaria | Mortality | Prophylaxis | Trimethoprim | Lymphocytes T | Antiretroviral therapy | CD4 antigen | Children & youth | Confidence intervals | Sulfamethoxazole | Human immunodeficiency virus--HIV | Sepsis | Meningitis | Children | Drug therapy | Age | Index Medicus | Abridged Index Medicus
Journal Article
JOURNAL OF PEDIATRICS, ISSN 0022-3476, 09/2016, Volume 176, pp. 222 - 222
Journal Article
Journal Article